Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | NICORANDIL | authKW | 456050 | 3% | 56% | 282 |
2 | CALCIUM ANTAGONISTS | authKW | 395232 | 4% | 29% | 476 |
3 | CALCIUM CHANNEL BLOCKERS | authKW | 231689 | 4% | 18% | 440 |
4 | AMLODIPINE | authKW | 210700 | 3% | 25% | 296 |
5 | LERCANIDIPINE | authKW | 193271 | 1% | 70% | 95 |
6 | NIFEDIPINE | authKW | 167239 | 3% | 16% | 357 |
7 | CILNIDIPINE | authKW | 165344 | 1% | 75% | 76 |
8 | LACIDIPINE | authKW | 159487 | 1% | 53% | 104 |
9 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | journal | 157641 | 7% | 7% | 777 |
10 | DILTIAZEM | authKW | 154753 | 2% | 23% | 238 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 56142 | 29% | 1% | 3124 |
2 | Pharmacology & Pharmacy | 52053 | 41% | 0% | 4440 |
3 | Peripheral Vascular Diseases | 16636 | 12% | 1% | 1307 |
4 | Medicine, General & Internal | 4503 | 11% | 0% | 1181 |
5 | Emergency Medicine | 1515 | 2% | 0% | 192 |
6 | Toxicology | 1217 | 4% | 0% | 429 |
7 | Chemistry, Medicinal | 1060 | 4% | 0% | 402 |
8 | Medicine, Research & Experimental | 841 | 5% | 0% | 492 |
9 | Chemistry, Analytical | 735 | 5% | 0% | 555 |
10 | Anesthesiology | 209 | 1% | 0% | 129 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HYPERTENS CARDIORENAL DIS | 10589 | 0% | 33% | 11 |
2 | MECH ATHEROGENESIS | 8676 | 0% | 100% | 3 |
3 | ANTIOXIDANT PHARMACOL | 6505 | 0% | 75% | 3 |
4 | CLIN PHARMACOL GERIATR MED | 6505 | 0% | 75% | 3 |
5 | INTERCELLULAR INTERACT | 6505 | 0% | 75% | 3 |
6 | CARDIOLMEMBRANE BIOPHYS | 5784 | 0% | 100% | 2 |
7 | PHYSIOL BIOCHEM SURG | 5784 | 0% | 100% | 2 |
8 | SPRINT STUDY GRP | 5784 | 0% | 100% | 2 |
9 | ANALYT PHARMACOKINET | 5203 | 0% | 60% | 3 |
10 | MED BIOCHEM CARDIOVASC BIOL | 5197 | 0% | 30% | 6 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 157641 | 7% | 7% | 777 |
2 | CARDIOVASCULAR DRUGS AND THERAPY | 34187 | 1% | 8% | 153 |
3 | AMERICAN JOURNAL OF CARDIOLOGY | 21704 | 4% | 2% | 456 |
4 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 21055 | 2% | 4% | 188 |
5 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 17671 | 2% | 3% | 211 |
6 | JOURNAL OF HUMAN HYPERTENSION | 12654 | 1% | 3% | 129 |
7 | AMERICAN JOURNAL OF HYPERTENSION | 12040 | 1% | 3% | 160 |
8 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 11982 | 2% | 2% | 187 |
9 | DRUGS | 11909 | 1% | 3% | 155 |
10 | JOURNAL OF HYPERTENSION | 11505 | 2% | 2% | 200 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NICORANDIL | 456050 | 3% | 56% | 282 | Search NICORANDIL | Search NICORANDIL |
2 | CALCIUM ANTAGONISTS | 395232 | 4% | 29% | 476 | Search CALCIUM+ANTAGONISTS | Search CALCIUM+ANTAGONISTS |
3 | CALCIUM CHANNEL BLOCKERS | 231689 | 4% | 18% | 440 | Search CALCIUM+CHANNEL+BLOCKERS | Search CALCIUM+CHANNEL+BLOCKERS |
4 | AMLODIPINE | 210700 | 3% | 25% | 296 | Search AMLODIPINE | Search AMLODIPINE |
5 | LERCANIDIPINE | 193271 | 1% | 70% | 95 | Search LERCANIDIPINE | Search LERCANIDIPINE |
6 | NIFEDIPINE | 167239 | 3% | 16% | 357 | Search NIFEDIPINE | Search NIFEDIPINE |
7 | CILNIDIPINE | 165344 | 1% | 75% | 76 | Search CILNIDIPINE | Search CILNIDIPINE |
8 | LACIDIPINE | 159487 | 1% | 53% | 104 | Search LACIDIPINE | Search LACIDIPINE |
9 | DILTIAZEM | 154753 | 2% | 23% | 238 | Search DILTIAZEM | Search DILTIAZEM |
10 | ISRADIPINE | 130279 | 1% | 37% | 122 | Search ISRADIPINE | Search ISRADIPINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |